Subtopic Deep Dive
TCM for Cardiovascular Diseases
Research Guide
What is TCM for Cardiovascular Diseases?
TCM for Cardiovascular Diseases applies Traditional Chinese Medicine herbs like Salvia miltiorrhiza and Astragalus polysaccharides in treating atherosclerosis, hypertension, and related conditions through clinical trials and network pharmacology analyses.
This subtopic reviews meta-analyses of TCM formulas such as Xuefu Zhuyu Tang for cardiovascular outcomes. Key herbs include Salvia miltiorrhiza (Danshen) with 522 citations (Li et al., 2018) and Astragalus polysaccharides with 409 citations (Zheng et al., 2020). Over 10 high-citation papers from 2008-2023 document efficacy and mechanisms.
Why It Matters
TCM herbs like Salvia miltiorrhiza reduce circulating adhesion molecules in CVD patients (O’Brien et al., 2008, 300 citations), offering adjunct therapies to synthetic drugs with side effects. Network pharmacology elucidates multi-target actions of TCM formulas (Zhang et al., 2023, 459 citations), supporting personalized treatments. Clinical applications include Danshen for atherosclerosis (Ren et al., 2019, 287 citations) and Astragalus for cardioprotection (Zheng et al., 2020, 409 citations), potentially lowering global CVD mortality.
Key Research Challenges
Heterogeneity in TCM Formulas
TCM prescriptions vary in composition, complicating meta-analyses of cardiovascular outcomes. Standardization issues hinder reproducible clinical trials (Shaito et al., 2020). Network pharmacology addresses this via multi-component modeling (Zhang et al., 2023).
Mechanistic Validation Gaps
Linking TCM herb actions like tanshinones to CVD pathways requires rigorous verification. Few studies integrate pharmacokinetics with efficacy data (Ren et al., 2019). Herbal safety profiles need long-term assessment (Su et al., 2015).
Integration with Western Medicine
Combining TCM adjuncts with standard CVD therapies demands interaction studies. Adhesion molecule reduction by Danshen-Notoginseng blends shows promise but needs larger RCTs (O’Brien et al., 2008). Evidence grading remains inconsistent across trials.
Essential Papers
Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics
Zhuo-ming Li, Suowen Xu, Peiqing Liu · 2018 · Acta Pharmacologica Sinica · 522 citations
The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer
Fanghua Qi, Lin Zhao, Aiyan Zhou et al. · 2015 · BioScience Trends · 465 citations
Recent studies indicate that Traditional Chinese medicine (TCM) can play an important role in the whole course of cancer treatment such as recovery stages of post-operative, radiotherapy or chemoth...
Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine
Peng Zhang, Dingfan Zhang, Wuai Zhou et al. · 2023 · Briefings in Bioinformatics · 459 citations
Abstract Network pharmacology (NP) provides a new methodological perspective for understanding traditional medicine from a holistic perspective, giving rise to frontiers such as traditional Chinese...
A Review of the Pharmacological Action of Astragalus Polysaccharide
Yijun Zheng, Weiyu Ren, Lina Zhang et al. · 2020 · Frontiers in Pharmacology · 409 citations
<i>Astragalus membranaceus</i> (<i>A. membranaceus</i>) is a type of traditional Chinese medicine with a long history of clinical application. It is used in the improvement and treatment of various...
Salvia miltiorrhiza: Traditional medicinal uses, chemistry, and pharmacology
Chunyan Su, Qianliang Ming, Khalid Rahman et al. · 2015 · Chinese Journal of Natural Medicines · 407 citations
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety
Abdullah Shaito, Duong Thi Bich Thuan, Hoa Thi Phu et al. · 2020 · Frontiers in Pharmacology · 394 citations
Cardiovascular diseases (CVDs) are a significant health burden with an ever-increasing prevalence. They remain the leading causes of morbidity and mortality worldwide. The use of medicinal herbs co...
Coriandrum sativum L.: A Review on Ethnopharmacology, Phytochemistry, and Cardiovascular Benefits
Nisa Najibah Mahleyuddin, Said Moshawih, Long Chiau Ming et al. · 2021 · Molecules · 382 citations
Coriandrum sativum (C. sativum), belonging to the Apiaceae (Umbelliferae) family, is widely recognized for its uses in culinary and traditional medicine. C. sativum contains various phytochemicals ...
Reading Guide
Foundational Papers
Start with O’Brien et al. (2008, 300 citations) for clinical evidence on Salvia-Notoginseng reducing CVD adhesion molecules, then Che et al. (2013, 260 citations) on herb combinations, and Kim (2012, 234 citations) on ginseng mechanisms.
Recent Advances
Study Zhang et al. (2023, 459 citations) for AI-driven network pharmacology, Zheng et al. (2020, 409 citations) on Astragalus polysaccharides, and Ren et al. (2019, 287 citations) on Danshen applications.
Core Methods
Core techniques: network pharmacology modeling (Zhang et al., 2023), meta-analyses of RCTs (Shaito et al., 2020), and phytochemical assays for tanshinones (Li et al., 2018).
How PapersFlow Helps You Research TCM for Cardiovascular Diseases
Discover & Search
Research Agent uses searchPapers and exaSearch to find meta-analyses on Salvia miltiorrhiza for CVD, then citationGraph on Li et al. (2018, 522 citations) reveals 50+ related works, while findSimilarPapers uncovers Astragalus studies (Zheng et al., 2020).
Analyze & Verify
Analysis Agent employs readPaperContent on O’Brien et al. (2008) to extract adhesion molecule data, verifyResponse with CoVe checks claims against 10 papers, and runPythonAnalysis performs meta-analysis statistics on effect sizes with GRADE grading for evidence strength in TCM trials.
Synthesize & Write
Synthesis Agent detects gaps in Danshen-tanshinone mechanisms via contradiction flagging across Ren et al. (2019) and Li et al. (2018); Writing Agent uses latexEditText, latexSyncCitations for 20-paper reviews, latexCompile for reports, and exportMermaid for network pharmacology diagrams.
Use Cases
"Extract and plot meta-analysis effect sizes from TCM hypertension trials"
Research Agent → searchPapers('TCM hypertension meta-analysis') → Analysis Agent → readPaperContent(5 papers) → runPythonAnalysis(pandas meta-regression, matplotlib forest plot) → researcher gets GRADE-scored effect size visualization.
"Draft LaTeX review on Salvia miltiorrhiza for atherosclerosis"
Synthesis Agent → gap detection(Zhang et al., 2023) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(Li et al., 2018; Ren et al., 2019) → latexCompile(PDF) → researcher gets compiled review with diagrams.
"Find code for TCM network pharmacology models"
Research Agent → searchPapers('TCM network pharmacology code') → paperExtractUrls(Zhang et al., 2023) → paperFindGithubRepo → githubRepoInspect → researcher gets validated Python scripts for herb-target networks.
Automated Workflows
Deep Research workflow conducts systematic reviews of 50+ Salvia miltiorrhiza papers: searchPapers → citationGraph → GRADE grading → structured report on CVD efficacy. DeepScan applies 7-step analysis to O’Brien et al. (2008) with CoVe checkpoints for adhesion molecule claims. Theorizer generates hypotheses on Astragalus-CVD synergies from Zheng et al. (2020) and Shaito et al. (2020).
Frequently Asked Questions
What defines TCM for Cardiovascular Diseases?
It involves herbs like Salvia miltiorrhiza and formulas targeting atherosclerosis via clinical trials and network pharmacology (Li et al., 2018; Zhang et al., 2023).
What are main methods in this subtopic?
Methods include meta-analyses of RCTs, network pharmacology for multi-target prediction, and adhesion molecule assays (O’Brien et al., 2008; Zheng et al., 2020).
What are key papers?
Top papers: Li et al. (2018, 522 citations) on Danshen; Zhang et al. (2023, 459 citations) on TCM network pharmacology; O’Brien et al. (2008, 300 citations) on herbal CAM reduction.
What open problems exist?
Challenges: formula standardization, long-term safety RCTs, and Western-TCM integration trials (Shaito et al., 2020; Ren et al., 2019).
Research Traditional Chinese Medicine Analysis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching TCM for Cardiovascular Diseases with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers